Rezultati

eNauka >  Results >  Neratinib after trastuzumab (T)-based adjuvant therapy in early-stage HER2+breast cancer (BC): 5-year analysis of the phase III ExteNET trial
Title: Neratinib after trastuzumab (T)-based adjuvant therapy in early-stage HER2+breast cancer (BC): 5-year analysis of the phase III ExteNET trial
Authors Jimenez, Martin M; ...; Tomasevic, Zoran M; ...; (broj, koautora 20)
Issue Date: 2017
Publication: ANNALS OF ONCOLOGY
ISSN: 0923-7534 Annals of Oncology Search Idenfier
Type: Conference Paper
Collation: vol. 28 str. v43-v43
DOI: 10.1093/annonc/mdx362
WoS-ID: 000411324000078
URI: https://enauka.gov.rs/handle/123456789/809472
Project: Puma Biotechnology
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

4
OpenCitations
Alt metrika
Dimensions
Unpaywall

Google ScholarTM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.